<DOC>
	<DOCNO>NCT02317744</DOCNO>
	<brief_summary>This study test effectiveness combination Naltrexone Bupropion relative placebo reduce binge eat person obesity binge eat disorder .</brief_summary>
	<brief_title>Treatment Binge Eating Disorder Obesity : Naltrexone/ Bupropion Combination Versus Placebo</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Feeding Eating Disorders</mesh_term>
	<mesh_term>Binge-Eating Disorder</mesh_term>
	<mesh_term>Bulimia</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<mesh_term>Bupropion hydrochloride , naltrexone hydrochoride drug combination</mesh_term>
	<criteria>Binge eat disorder ( full criterion describe American Psychiatric Association Diagnostic Statistical Manual Mental Disorders , 5th edition ) BMI 30 kg/m2 50 kg/m2 Not take antidepressant medication Read English proficiently enough read study assessment Available duration treatment plus followup period Able travel study location ( New Haven , CT ) monthly visit Agree study procedure Medical status judge study physician contraindication History seizures Past current anorexia nervosa , bulimia nervosa Current medication influence eating/weight Current substance use disorder severe psychiatric disturbance ( e.g. , suicidality ) require immediate treatment Pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>